Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study

Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study

Objectives: The aim of this study was to describe the population pharmacokinetics of intravenous colistin use in children and to propose optimal dosage regimens. Methods: A prospective, multicenter, population pharmacokinetic (PPK) study was conducted. Phoenix 64 version 8.3 was used for the PPK ana...

Full description

Bibliographic Details
Main Authors:	Noppadol Wacharachaisurapol, Warumphon Sukkummee, Orawan Anunsittichai, Panida Srisan, Siriporn Sangkhamal, Prawat Chantharit, Warunee Punpanich Vandepitte, Thitima Wattanavijitkul, Thanyawee Puthanakit
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	International Journal of Infectious Diseases
Subjects:	Colistin Pharmacokinetics Pediatrics Multidrug-resistant bacteria
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221005397

Similar Items

No increased acute kidney injury rate through giving an intravenous colistin loading dose in pediatric patients
by: Noppadol Wacharachaisurapol, et al.
Published: (2021-05-01)

Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in paediatric patients
by: Tatchanapong Chongcharoenyanon, et al.
Published: (2021-07-01)

Optimising the dosing of antibiotics: Colistin and vancomycin updates
by: Reklia Solomon, et al.
Published: (2015-01-01)

Endogenous endophthalmitis due to multidrug-resistant Pseudomonas aeruginosa treated with colistin: A case series
by: Pradeep Kumar Panigrahi, et al.
Published: (2021-01-01)

Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals
by: Saghar Jafari-Ramedani, et al.
Published: (2024-05-01)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
by: Bahareh Vakili, et al.
Published: (2014-01-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients
by: Ayşe Karaaslan, et al.
Published: (2016-12-01)

Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran
by: Hamid Reza Goli, et al.
Published: (2016-03-01)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
by: Mohd Shafie Zabidi, et al.
Published: (2021-09-01)

Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
by: Bin Liu, et al.
Published: (2014-07-01)

Postoperative endophthalmitis due to multidrug-resistant Klebsiella pneumoniae treated successfully with intravitreal colistin and core vitrectomy
by: Amit Kumar Deb, et al.
Published: (2020-01-01)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
by: Yaxin Fan, et al.
Published: (2022-06-01)

Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study
by: Thamer A. Almangour, et al.
Published: (2022-03-01)

Pathogenic Lineage of mcr-Negative Colistin-Resistant Escherichia coli, Japan, 2008–2015
by: Toyotaka Sato, et al.
Published: (2016-12-01)

Mobile Plasmid Mediated Transition From Colistin-Sensitive to Resistant Phenotype in Klebsiella pneumoniae
by: Baoyue Zhang, et al.
Published: (2021-02-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

First report of the mcr-1 colistin resistance gene identified in two Escherichia coli isolates from clinical samples, Philippines, 2018
by: John Mark S. Velasco, et al.
Published: (2020-06-01)

Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges
by: Ferdinando F. Andrade, et al.
Published: (2020-11-01)

Detection and Characterisation of Colistin-Resistant <i>Escherichia coli</i> in Broiler Meats
by: Abu Zubayer Tanzin, et al.
Published: (2024-12-01)

Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
by: Mohamed Abd El-Gawad El-Sayed Ahmed, et al.
Published: (2020-01-01)

In Vitro Susceptibility of Colistin Against Multidrug Resistant Klebsiella Pneumoniae Clinical Isolates
by: Muhammad Fayyaz, et al.
Published: (2022-11-01)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021-01-01)

Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii
by: Nalumon Thadtapong, et al.
Published: (2024-04-01)

An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review
by: Mohammad H. Gharaibeh, et al.
Published: (2019-11-01)

Pattern of colistin resistance in Klebsiella isolates in an Intensive Care Unit of a tertiary care hospital in India
by: Kanwalpreet Sodhi, et al.
Published: (2020-07-01)

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
by: Yinggang Zhu, et al.
Published: (2021-05-01)

A study of multidrug-resistant, colistin-only-sensitive infections in intubated and mechanically ventilated patients over 2 years
by: Ipe Jacob, et al.
Published: (2020-01-01)

Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC)
by: Hao Lu, et al.
Published: (2020-05-01)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
by: Kritsaporn Sujjavorakul, et al.
Published: (2023-03-01)

Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria in Vitro and in Vivo
by: Ying Zhang, et al.
Published: (2021-12-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter Cohort Study
by: Thamer A. Almangour, et al.
Published: (2025-01-01)

Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection
by: W. Wangchinda, et al.
Published: (2018-07-01)

Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates
by: Yuan Wang, et al.
Published: (2024-04-01)

Emergence of Mobilized Colistin Resistance Gene mcr-8.2 in Multidrug-Resistant Enterobacter cloacae Isolated from a Patient in China
by: Siheng Wang, et al.
Published: (2022-08-01)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
by: Xiaoxuan Feng, et al.
Published: (2021-06-01)

Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
by: Antonio Cannatelli, et al.
Published: (2018-08-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection
by: Weeraya Phaisal, et al.
Published: (2022-09-01)